Lubdub Funding: How Much Did They Raise & Key Investors

How Much Did Lubdub Raise?
Funding & Key Investors

Lubdub, an emerging leader in the Australian health-tech sector, has successfully secured a major strategic investment, bringing its total capital accumulation to $100K. This latest infusion of $100K marks a pivotal moment for the Perth and Melbourne-based firm as it transitions from early-stage development into a more robust operational phase. By leveraging this significant financial backing, the company is well-positioned to accelerate its mission of democratizing cardiac diagnostics through its proprietary integrated hardware ecosystem.

What is Lubdub?

Lubdub

Manufacturing

Medical Devices & Equipment

Healthcare Software

Lubdub Technologies is redefining the landscape of preventative cardiology with its innovative hearthealthinabox platform. The company specializes in a multi-modal diagnostic approach that integrates wearable ECG patches, saliva-based cardiac biomarker sensors, and portable ultrasound technology. This comprehensive suite of tools allows for continuous, real-time heart monitoring, effectively bridging the gap between clinical-grade diagnostics and consumer-accessible health tracking. By consolidating these disparate technologies into a single, cohesive solution, Lubdub addresses the critical need for early detection and longitudinal data collection in cardiovascular health management. The firm's strategic focus on remote monitoring positions it at the intersection of digital health and personalized medicine, catering to an aging global population and a growing demand for proactive wellness solutions.

How much funding has Lubdub raised?

Lubdub has raised a total of $100K across 1 funding round:

2025

Seed

$100K

Seed (2025): $100K, investors not publicly disclosed

Key Investors in Lubdub

Lubdub

Undisclosed investor participating in the funding round.

What's next for Lubdub?

With the recent injection of capital, Lubdub is expected to prioritize the scaling of its manufacturing capabilities and the expansion of its clinical validation studies. The company's roadmap likely includes navigating complex regulatory pathways to ensure its diagnostic tools meet international standards for medical devices. Furthermore, the strategic deployment of these funds will facilitate the refinement of its data analytics engine, which is essential for interpreting the complex biometric inputs generated by its sensor suite. As the firm matures, it will likely seek to establish partnerships with healthcare providers and insurance entities to integrate its technology into standard care protocols, thereby solidifying its market presence and driving long-term value for stakeholders in the rapidly evolving health-tech ecosystem.

See full Lubdub company page

See More Financial Insights